Holger Weis

Holger Weis is recorded as CEO at Alaunos Therapeutics, Inc. (TCRT) since July 2, 2025, Chairman at Alaunos Therapeutics, Inc. (TCRT) since September 22, 2023, Board Member at Alaunos Therapeutics, Inc. (TCRT) and Board Member at Jupiter Neurosciences, Inc. (JUNS). The newest filing on record that lists Holger Weis as Board Member at Alaunos Therapeutics, Inc. (TCRT) is dated May 21, 2025. The newest filing on record that lists Holger Weis as Board Member at Jupiter Neurosciences, Inc. (JUNS) is dated June 22, 2026. Jupiter Neurosciences, Inc. reported in an 8-K filed December 22, 2025 that Holger Weis was appointed director, effective December 19, 2025. Alaunos Therapeutics, Inc. reported in an 8-K filed July 17, 2025 that Holger Weis was appointed Chief Executive Officer. Alaunos Therapeutics, Inc. reported in an 8-K filed July 2, 2025 that Holger Weis was appointed Chief Executive Officer, effective July 2, 2025. Equibles holds 4 filed executive changes naming Holger Weis; each is listed under recent activity with its source filing. Alaunos Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Jupiter Neurosciences, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Alaunos Therapeutics, Inc. includes Dale Curtis Hogue, Jr. (CEO and Board Member), Heidi Hagen (CEO and Board Member), Kevin Boyle (CEO and Board Member) and 7 others.